Hana Must SPAC 2 (208370) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hana Must SPAC 2 (208370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩838.06 Million ≈ $567.94K USD) by net assets (₩63.95 Billion ≈ $43.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hana Must SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Hana Must SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Hana Must SPAC 2 balance sheet liabilities for a breakdown of total debt and financial obligations.
Hana Must SPAC 2 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hana Must SPAC 2 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ak Holdings
KO:006840
|
0.084x |
|
Danang Rubber JSC
VN:DRC
|
0.052x |
|
Vinyl Group Ltd
AU:VNL
|
-0.277x |
|
Hwacheon Machi
KO:010660
|
-0.024x |
|
QPM Energy Ltd
AU:QPM
|
0.164x |
|
Billion Electric Co Ltd
TW:3027
|
-0.017x |
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
2.795x |
|
United Polyfab Gujarat Limited
NSE:UNITEDPOLY
|
0.101x |
Annual Cash Flow Conversion Efficiency for Hana Must SPAC 2 (2015–2024)
The table below shows the annual cash flow conversion efficiency of Hana Must SPAC 2 from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 208370 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩63.80 Billion ≈ $43.24 Million |
₩4.50 Billion ≈ $3.05 Million |
0.071x | +22.09% |
| 2023-12-31 | ₩60.10 Billion ≈ $40.73 Million |
₩3.47 Billion ≈ $2.35 Million |
0.058x | +3640.27% |
| 2022-12-31 | ₩32.89 Billion ≈ $22.29 Million |
₩50.81 Million ≈ $34.43K |
0.002x | -98.52% |
| 2021-12-31 | ₩28.06 Billion ≈ $19.02 Million |
₩2.93 Billion ≈ $1.98 Million |
0.104x | -38.53% |
| 2020-12-31 | ₩24.89 Billion ≈ $16.87 Million |
₩4.23 Billion ≈ $2.86 Million |
0.170x | +11.18% |
| 2019-12-31 | ₩24.14 Billion ≈ $16.36 Million |
₩3.69 Billion ≈ $2.50 Million |
0.153x | +132.33% |
| 2018-12-31 | ₩14.60 Billion ≈ $9.90 Million |
₩-6.90 Billion ≈ $-4.67 Million |
-0.472x | -205.32% |
| 2017-12-31 | ₩27.81 Billion ≈ $18.85 Million |
₩-4.30 Billion ≈ $-2.92 Million |
-0.155x | +33.13% |
| 2016-12-31 | ₩26.92 Billion ≈ $18.24 Million |
₩-6.23 Billion ≈ $-4.22 Million |
-0.231x | -2788.35% |
| 2015-12-31 | ₩19.09 Billion ≈ $12.94 Million |
₩164.29 Million ≈ $111.33K |
0.009x | -- |
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more